Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo

Junko Matsuzaki, Takemasa Tsuji, Kenji Chamoto, Tsuguhide Takeshima, Fujiro Sendo, Takashi Nishimura

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

During investigating the expression of Gr-1 antigen on various subsets of mouse spleen cells, we found that Gr-1 was expressed on memory-type CD8 +CD44highCD62Lhigh T cells in addition to granulocytes. Intraperitoneal administration of anti-Gr-1 mAb caused almost complete elimination of Ly-6C+ memory-type CD8+ T cells as well as Ly-6G+ granulocytes. Anti-Gr-1 mAb-treated mouse spleen cells exhibited greatly reduced IFN-γ production in response to anti-CD3 mAb both in vitro and in vivo. This reduced cytokine production appeared to be derived from elimination of IFN-γ-producing Gr-1+CD8 + T cells. Indeed, CD8+ T cells with IFN-γ- producing activity and cytotoxicity were generated from isolated Gr-1 +CD8+ cells but not from Gr-1-CD8+ T cells. We also demonstrated that therapeutic effect of MBL-2 tumor-immunized spleen cells was greatly reduced by anti-Gr-1 mAb-treatment. Thus, we initially demonstrated that anti-Gr-1 mAb might become a good tool to investigate a precise role for memory-type CD8+ T cells in vivo.

Original languageEnglish (US)
Pages (from-to)97-104
Number of pages8
JournalCellular Immunology
Volume224
Issue number2
DOIs
StatePublished - Aug 2003

Fingerprint

T-Lymphocyte Subsets
Monoclonal Antibodies
T-Lymphocytes
Spleen
Granulocytes
Therapeutic Uses
Cytokines
Antigens
Neoplasms

Keywords

  • Antitumor activity
  • CD8 T cell
  • Gr-1
  • IFN-γ
  • Memory-type

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. / Matsuzaki, Junko; Tsuji, Takemasa; Chamoto, Kenji; Takeshima, Tsuguhide; Sendo, Fujiro; Nishimura, Takashi.

In: Cellular Immunology, Vol. 224, No. 2, 08.2003, p. 97-104.

Research output: Contribution to journalArticle

Matsuzaki, Junko ; Tsuji, Takemasa ; Chamoto, Kenji ; Takeshima, Tsuguhide ; Sendo, Fujiro ; Nishimura, Takashi. / Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. In: Cellular Immunology. 2003 ; Vol. 224, No. 2. pp. 97-104.
@article{ac702f51b5c54931b11d64d6a3769aaa,
title = "Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo",
abstract = "During investigating the expression of Gr-1 antigen on various subsets of mouse spleen cells, we found that Gr-1 was expressed on memory-type CD8 +CD44highCD62Lhigh T cells in addition to granulocytes. Intraperitoneal administration of anti-Gr-1 mAb caused almost complete elimination of Ly-6C+ memory-type CD8+ T cells as well as Ly-6G+ granulocytes. Anti-Gr-1 mAb-treated mouse spleen cells exhibited greatly reduced IFN-γ production in response to anti-CD3 mAb both in vitro and in vivo. This reduced cytokine production appeared to be derived from elimination of IFN-γ-producing Gr-1+CD8 + T cells. Indeed, CD8+ T cells with IFN-γ- producing activity and cytotoxicity were generated from isolated Gr-1 +CD8+ cells but not from Gr-1-CD8+ T cells. We also demonstrated that therapeutic effect of MBL-2 tumor-immunized spleen cells was greatly reduced by anti-Gr-1 mAb-treatment. Thus, we initially demonstrated that anti-Gr-1 mAb might become a good tool to investigate a precise role for memory-type CD8+ T cells in vivo.",
keywords = "Antitumor activity, CD8 T cell, Gr-1, IFN-γ, Memory-type",
author = "Junko Matsuzaki and Takemasa Tsuji and Kenji Chamoto and Tsuguhide Takeshima and Fujiro Sendo and Takashi Nishimura",
year = "2003",
month = "8",
doi = "10.1016/j.cellimm.2003.08.009",
language = "English (US)",
volume = "224",
pages = "97--104",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo

AU - Matsuzaki, Junko

AU - Tsuji, Takemasa

AU - Chamoto, Kenji

AU - Takeshima, Tsuguhide

AU - Sendo, Fujiro

AU - Nishimura, Takashi

PY - 2003/8

Y1 - 2003/8

N2 - During investigating the expression of Gr-1 antigen on various subsets of mouse spleen cells, we found that Gr-1 was expressed on memory-type CD8 +CD44highCD62Lhigh T cells in addition to granulocytes. Intraperitoneal administration of anti-Gr-1 mAb caused almost complete elimination of Ly-6C+ memory-type CD8+ T cells as well as Ly-6G+ granulocytes. Anti-Gr-1 mAb-treated mouse spleen cells exhibited greatly reduced IFN-γ production in response to anti-CD3 mAb both in vitro and in vivo. This reduced cytokine production appeared to be derived from elimination of IFN-γ-producing Gr-1+CD8 + T cells. Indeed, CD8+ T cells with IFN-γ- producing activity and cytotoxicity were generated from isolated Gr-1 +CD8+ cells but not from Gr-1-CD8+ T cells. We also demonstrated that therapeutic effect of MBL-2 tumor-immunized spleen cells was greatly reduced by anti-Gr-1 mAb-treatment. Thus, we initially demonstrated that anti-Gr-1 mAb might become a good tool to investigate a precise role for memory-type CD8+ T cells in vivo.

AB - During investigating the expression of Gr-1 antigen on various subsets of mouse spleen cells, we found that Gr-1 was expressed on memory-type CD8 +CD44highCD62Lhigh T cells in addition to granulocytes. Intraperitoneal administration of anti-Gr-1 mAb caused almost complete elimination of Ly-6C+ memory-type CD8+ T cells as well as Ly-6G+ granulocytes. Anti-Gr-1 mAb-treated mouse spleen cells exhibited greatly reduced IFN-γ production in response to anti-CD3 mAb both in vitro and in vivo. This reduced cytokine production appeared to be derived from elimination of IFN-γ-producing Gr-1+CD8 + T cells. Indeed, CD8+ T cells with IFN-γ- producing activity and cytotoxicity were generated from isolated Gr-1 +CD8+ cells but not from Gr-1-CD8+ T cells. We also demonstrated that therapeutic effect of MBL-2 tumor-immunized spleen cells was greatly reduced by anti-Gr-1 mAb-treatment. Thus, we initially demonstrated that anti-Gr-1 mAb might become a good tool to investigate a precise role for memory-type CD8+ T cells in vivo.

KW - Antitumor activity

KW - CD8 T cell

KW - Gr-1

KW - IFN-γ

KW - Memory-type

UR - http://www.scopus.com/inward/record.url?scp=0242333943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242333943&partnerID=8YFLogxK

U2 - 10.1016/j.cellimm.2003.08.009

DO - 10.1016/j.cellimm.2003.08.009

M3 - Article

C2 - 14609575

AN - SCOPUS:0242333943

VL - 224

SP - 97

EP - 104

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 2

ER -